TBRG
TruBridge, Inc.NASDAQHealthcare$16.24+5.54%ClosedMarket Cap: $243.7M
As of 2026-04-06
Valuation
P/E (TTM)
55.98
PEG
0.46
P/B
1.40
P/S
0.74
EV/EBITDA
9.40
DCF Value
$22.11
FCF Yield
28.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.0%
Operating Margin
6.0%
Net Margin
1.3%
ROE
2.5%
ROA
1.1%
ROIC
6.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $87.8M | 54.3% | $5.0M | $-4.3M | $-0.28 | — |
| FY 2025 | $346.8M | 53.0% | $20.8M | $4.4M | $0.29 | — |
| Q3 2025 | $86.1M | 51.2% | $4.1M | $5.6M | $0.37 | — |
| Q2 2025 | $85.7M | 51.9% | $3.6M | $2.6M | $0.17 | — |
| Q1 2025 | $87.2M | 54.7% | $8.2M | $459.0K | $0.03 | — |
| Q4 2024 | $90.8M | 54.8% | $9.2M | $-3.1M | $-0.39 | — |
| FY 2024 | $342.6M | 50.8% | $6.6M | $-20.4M | $-1.38 | — |
| Q3 2024 | $83.8M | 49.5% | $1.9M | $-9.8M | $0.45 | — |
| Q2 2024 | $85.6M | 49.4% | $-2.1M | $-4.4M | $-0.29 | — |
| Q1 2024 | $84.1M | 50.4% | $-588.0K | $-1.9M | $-0.17 | — |
| Q4 2023 | $85.9M | 49.1% | $-41.8M | $-42.5M | $-2.92 | — |
| FY 2023 | $339.4M | 48.2% | $-42.6M | $-45.8M | $-3.15 | — |